ADDITIONS AND PROMOTIONS

AbelsonTaylor - has promoted Marissa Ori and Eric Pernot to associate creative directors. Kurt Stirnkorb is hired as senior interactive developer

Carbon - has promoted David Winkler to VP management supervisor and Brian Conway to account supervisor. Linda Ciccarellii and /Stacy Fillippone become account group supervisors. Andrea O'Brien is added as account supervisor and Aaron Neitfeld and Michelle Schmidt become senior account executives. Brooke Sinclair has been added as account executive and Debi Post becomes business manager. Jaclyn Ferguson, Brian Drown and Timothy Henderson become account coordinators, and Natalie Fox is added as a copywriter.

Centron - has added Carmen McMonagale becomes VP account group supervisor, and Hue Nguyen becomes senior account executive. Diane Martin is named associate creative director and Paul Lawson is named creative supervisor. Hope Sackin becomes senior art director and Glynis Samuel becomes senior project manager/ Jenny Fuks becomes medical editor and Jeanette Phelps becomes project manager.

Commonhealth - has promoted Barbara Bochese to VP director of operations,information technology.

The Hal Lewis Group - has added Chelsea Thompsom as editor and David Chatfield has been added as graphic designer.

HC&B Healthcare - has added Mandy Buhler as media director.

Noesis - has promoted Eric Martin to senior art director and Jessica Kraske to account executive. Michael Ferrari has been added as account executive and Junsuk Yand as art director. Nina Giannone has been hired as account coordinator.

Seidler Bernstin Inc. - has promoted Nicole Woodland-DeVan to vice president

GSW Worldwide - has named Nik See as director of brand planning and strategy, and Angel Micarelli becomes account supervisor. Jennifer Charron is named account manaager and Leslie Loock is promoted to project manager.

HAND-PICKED PHARMA NEWS

Merck Cholesterol Woes May Rise on Loss to Abbott

Desire Drug May Prove Sex Really Is All in Her Head

Merck AIDS Vaccine Failure Tied to Common Cold Virus

US FDA declines to approve Discovery Lab's lung drug

Glaxo to Acquire Stiefel Laboratories for $2.9 Billion